{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:01:28Z","timestamp":1775210488631,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sophisticated Analytical Instruments Facility (SAIF), Punjab University, Chandigarh, India, Indian Institute of Technology, Powai, Bombay, MS, India, Biophore India and Principal, Dr. S. J. Surana"},{"name":"R C. Patel Institute of Pharmaceutical Education and Research, Shirpur (MS), India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jpba.2019.112982","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:35:42Z","timestamp":1573817742000},"page":"112982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery"],"prefix":"10.1016","volume":"179","author":[{"given":"Saurabh B.","family":"Ganorkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Vander Heyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul A.","family":"Shirkhedkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak K.","family":"Lokwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh M.","family":"Dhumal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti S.","family":"Bobade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.112982_bib0005","series-title":"The World Health Organization: Working for Better Health for Everyone, Everywhere (No. WHO\/DCO\/18.1)","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jpba.2019.112982_bib0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2018.03.010","article-title":"Asthma across the lifespan: time for a paradigm shift","volume":"142","author":"Szefler","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2019.112982_bib0015","article-title":"Zileuton use and phenotypic features in asthma. C37. Optimizing asthma care across diverse patients. American thoracic society","volume":"197","author":"Muthukrishnan","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jpba.2019.112982_bib0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0021-9673(92)80382-5","article-title":"Preparative separation and analysis of the enantiomers of [14C] Zileuton, a 5-lipoxygenase inhibitor","volume":"623","author":"Thomas","year":"1992","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2019.112982_bib0025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1023\/A:1015819115075","article-title":"Kinetics and mechanism of degradation of zileuton, a potent 5-lipoxygenase inhibitor","volume":"9","author":"Alvarez","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2019.112982_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199500292-00003","article-title":"Determination of a new 5-lipoxygenase inhibitor, zileuton, and its inactive N-dehydroxylated metabolite in plasma by high performance liquid chromatography","volume":"29","author":"Granneman","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2019.112982_bib0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/10826079608001928","article-title":"Simultaneous determination of the 5-lipoxygenase inhibitor \u201czileuton\u2019\u2019 and its N-dehydroxylated metabolite in untreated rat urine by micellar liquid chromatography","volume":"19","author":"Thomas","year":"1996","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2019.112982_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0928-0987(95)00038-0","article-title":"Solubility and stability characterization of zileuton in a ternary solvent system","volume":"4","author":"Trivedi","year":"1996","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2019.112982_bib0045","first-page":"166","article-title":"Electrochemical reduction behaviour of zileuton at a dropping mercury electrode by polarography","volume":"7","author":"Shreedhar","year":"2010","journal-title":"E-J. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0050","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.14233\/ajchem.2017.20737","article-title":"Sensitive and validated voltammetric methods for determination of zileuton in serum, urine and pharmaceutical dosage forms at activated glassy carbon electrode","volume":"29","author":"Alhemiary","year":"2017","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.53879\/id.50.06.p0040","article-title":"Application of UV-spectrophotometry for determination of zileuton in bulk and in tablets","volume":"50","author":"Ganorkar","year":"2013","journal-title":"Indian J. Drugs Dermatol."},{"key":"10.1016\/j.jpba.2019.112982_bib0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.arabjc.2013.05.013","article-title":"Novel HPTLC and UV-AUC analyses: for simple, economical, and rapid determination of Zileuton racemate","volume":"10","author":"Ganorkar","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.arabjc.2014.03.009","article-title":"Development and validation of simple RP-HPLC-PDA analytical protocol for zileuton assisted with design of experiments for robustness determination","volume":"10","author":"Ganorkar","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0070","first-page":"1","article-title":"Highly sensitive determination of zileuton using TiO2 nanoparticles and the ionic liquid 1-hexylpyridinium hexafluorophosphate nanocomposite sensor","volume":"24","author":"Baezzat","year":"2018","journal-title":"Ionics"},{"key":"10.1016\/j.jpba.2019.112982_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mtcomm.2018.12.013","article-title":"Molecularly imprinted polymer based sensor for measuring of zileuton: evaluation as a modifier for carbon paste electrode in electrochemically recognition","volume":"19","author":"Baezzat","year":"2018","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.jpba.2019.112982_bib0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/17460441.2015.1006195","article-title":"Multitasking models for quantitative structure\u2013biological effect relationships: current status and future perspectives to speed up drug discovery","volume":"10","author":"Speck-Planche","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jpba.2019.112982_bib0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1021\/tx2000398","article-title":"Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations","volume":"24","author":"Hillebrecht","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2019.112982_bib0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acs.chemrestox.5b00388","article-title":"Current and future perspectives on the development, evaluation, and application of in silico approaches for predicting toxicity","volume":"29","author":"Patlewicz","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2019.112982_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/wcms.18","article-title":"Outstanding challenges in protein\u2013ligand docking and structure-based virtual screening","volume":"1","author":"Waszkowycz","year":"2011","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.jpba.2019.112982_bib0100","first-page":"31","article-title":"Practices in molecular docking and structure-based virtual screening","volume":"vol. 1762","author":"dos Santos","year":"2018"},{"key":"10.1016\/j.jpba.2019.112982_bib0105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/1062936X.2017.1408683","article-title":"Pharmacological repositioning of Achyranthes aspera as an antidepressant using pharmacoinformatic tools PASS and PharmaExpert: a case study with wet lab validation","volume":"29","author":"Goel","year":"2018","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jpba.2019.112982_bib0115","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3390\/md13042407","article-title":"Synthesis and bioactivity of Luffarin I","volume":"13","author":"Urosa","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jpba.2019.112982_bib0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpba.2018.06.036","article-title":"LC\/QTOF\/MS\/MS characterization, molecular docking and in silico toxicity prediction studies on degradation products of anagliptin","volume":"159","author":"Baira","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.112982_bib0125","first-page":"1071","article-title":"Quantitative structure activity-relationships for toxicity screening of pesticide impurities for regulatory submission\u2013practical experiences and challenges","volume":"99","author":"Pudenz","year":"2017","journal-title":"Toxicol. Environ. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0130","series-title":"United States Pharmacopeia 34-NF 29, Through Second Supplement","year":"2011"},{"key":"10.1016\/j.jpba.2019.112982_bib0135","series-title":"Stability Testing of New Drug Substances and Products (Current Step 4), November","author":"ICH guidelines Q1A (R2)","year":"2003"},{"key":"10.1016\/j.jpba.2019.112982_bib0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bioorg.2016.06.004","article-title":"Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives","volume":"67","author":"Srivastava","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jpba.2019.112982_bib0145","series-title":"In Silico Methods for Predicting Drug Toxicity","first-page":"107","article-title":"In silico methods for carcinogenicity assessment","author":"Golbamaki","year":"2016"},{"key":"10.1016\/j.jpba.2019.112982_bib0150","doi-asserted-by":"crossref","first-page":"18803","DOI":"10.1039\/C7RA00678K","article-title":"Stability behaviour of antiretroviral drugs and their combinations. 6: evidence of formation of potentially toxic degradation products of zidovudine under hydrolytic and photolytic conditions","volume":"7","author":"Kurmi","year":"2017","journal-title":"RSC Adv."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851931948X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851931948X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:01:23Z","timestamp":1760000483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851931948X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"alternative-id":["S073170851931948X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.112982","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.112982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112982"}}